Table 2.

Stratify analysis of YTHDF2 rs3738067 A>G polymorphism with Wilms tumor risk

Variables	rs3738067 (case/control)		Crude OR	P	Adjusted OR a	P a
	AA	AG/GG	(95% CI)		(95% CI)
Age, month
≤18	84/272	59/228	0.84 (0.58-1.22)	0.357	0.86 (0.59-1.25)	0.431
>18	169/459	129/357	0.98 (0.75-1.28)	0.891	1.00 (0.76-1.31)	0.990
Gender
Females	111/320	96/248	1.12 (0.81-1.54)	0.501	1.13 (0.82-1.55)	0.467
Males	142/411	92/337	0.79 (0.59-1.07)	0.123	0.79 (0.59-1.07)	0.129
Clinical stages
I	83/731	54/585	0.81 (0.57-1.17)	0.259	0.82 (0.57-1.17)	0.274
II	70/731	49/585	0.88 (0.60-1.28)	0.491	0.88 (0.60-1.28)	0.500
III	63/731	54/585	1.07 (0.73-1.57)	0.723	1.05 (0.72-1.54)	0.809
IV	29/731	23/585	0.99 (0.57-1.73)	0.975	0.98 (0.60-1.71)	0.937
I+II	153/731	103/585	0.84 (0.64-1.11)	0.214	0.84 (0.64-1.11)	0.221
III+IV	92/731	77/585	1.05 (0.76-1.44)	0.785	1.02 (0.74-1.41)	0.901

OR, odds ratio; CI, confidence interval.

^a Adjusted for age and gender, omitting the corresponding variable.